{
  "pmid": "24702240",
  "uid": "24702240",
  "title": "Letter to the editor.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Druyts",
      "fore_name": "Eric",
      "initials": "E",
      "name": "Eric Druyts",
      "affiliations": [
        "Faculty of Health Sciences, University of Ottawa , Ottawa, ON , Canada."
      ]
    },
    {
      "last_name": "Thorlund",
      "fore_name": "Kristian",
      "initials": "K",
      "name": "Kristian Thorlund",
      "affiliations": []
    },
    {
      "last_name": "Mills",
      "fore_name": "Edward J",
      "initials": "EJ",
      "name": "Edward J Mills",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Journal of medical economics",
    "iso_abbreviation": "J Med Econ",
    "issn": "1941-837X",
    "issn_type": "Electronic",
    "volume": "17",
    "issue": "7",
    "pub_year": "2014",
    "pub_month": "Jul"
  },
  "start_page": "445",
  "pages": "445",
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Comment"
  ],
  "keywords": [
    "Antiviral Agents",
    "Drug Therapy, Combination",
    "Hepatitis C, Chronic",
    "Humans",
    "Interferon-alpha",
    "Oligopeptides",
    "Polyethylene Glycols",
    "Proline",
    "Ribavirin"
  ],
  "article_ids": {
    "pubmed": "24702240",
    "doi": "10.3111/13696998.2014.909438"
  },
  "doi": "10.3111/13696998.2014.909438",
  "dates": {
    "completed": "2015-02-23",
    "revised": "2018-12-02"
  },
  "chemicals": [
    "Antiviral Agents",
    "Interferon-alpha",
    "Oligopeptides",
    "Polyethylene Glycols",
    "Ribavirin",
    "Proline"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T15:02:51.499978",
    "pmid": "24702240"
  }
}